Indian pharmaceutical stocks witnessed a decline as a result of Donald Trump’s recent warning about imposing tariffs on pharmaceutical imports. The Nifty Pharma index dropped by 1.7%, with leading companies such as Gland Pharma and Sun Pharma bearing the brunt of the downturn. Trump’s remarks emphasized the push to encourage pharmaceutical firms to relocate their manufacturing operations to the United States by using tariffs, which could have a significant impact on India’s extensive generic drug exports to the US.